These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
64 related items for PubMed ID: 15816612
1. Occult cancer detected by positron emission tomography/computed tomography image fusion. Watanabe S, Tanaka D, Nakamura Y, Kariatsumari K, Fukumori K, Ohkubo J, Sakata R, Takagi K. Anticancer Res; 2005; 25(1B):459-61. PubMed ID: 15816612 [Abstract] [Full Text] [Related]
3. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ, Zhang YX, Wei H, Jia Q. Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544 [Abstract] [Full Text] [Related]
4. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF. J Nucl Med; 2005 Jul 28; 46(7):1136-43. PubMed ID: 16000282 [Abstract] [Full Text] [Related]
5. Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature. Dong MJ, Zhao K, Lin XT, Zhao J, Ruan LX, Liu ZF. Nucl Med Commun; 2008 Sep 28; 29(9):791-802. PubMed ID: 18677207 [Abstract] [Full Text] [Related]
6. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer. Sato M, Okumura T, Kaito K, Kiyoshima M, Asato Y, Uchiumi K, Iijima H, Hashimoto I, Kaburagi T, Amemiya R. Ann Nucl Med; 2009 Jan 28; 23(1):49-57. PubMed ID: 19205838 [Abstract] [Full Text] [Related]
7. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer. Fukunaga H, Sekimoto M, Ikeda M, Higuchi I, Yasui M, Seshimo I, Takayama O, Yamamoto H, Ohue M, Tatsumi M, Hatazawa J, Ikenaga M, Nishimura T, Monden M. Ann Surg Oncol; 2005 Jul 28; 12(7):561-9. PubMed ID: 15889211 [Abstract] [Full Text] [Related]
8. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. Basu D, Siegel BA, McDonald DJ, Nussenbaum B. Arch Otolaryngol Head Neck Surg; 2007 Aug 28; 133(8):801-5. PubMed ID: 17709620 [Abstract] [Full Text] [Related]
9. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Zimmer LA, Branstetter BF, Nayak JV, Johnson JT. Laryngoscope; 2005 Nov 28; 115(11):2029-34. PubMed ID: 16319618 [Abstract] [Full Text] [Related]
10. Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area. Vogel WV, Schinagl DA, Van Dalen JA, Kaanders JH, Oyen WJ. Q J Nucl Med Mol Imaging; 2008 Mar 28; 52(1):74-83. PubMed ID: 17380097 [Abstract] [Full Text] [Related]
12. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Deantonio L, Beldì D, Gambaro G, Loi G, Brambilla M, Inglese E, Krengli M. Radiat Oncol; 2008 Sep 18; 3():29. PubMed ID: 18801181 [Abstract] [Full Text] [Related]
13. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S. Ann Surg; 2007 Dec 18; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [Abstract] [Full Text] [Related]
14. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A. Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228 [Abstract] [Full Text] [Related]
15. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, Ohbayashi C, Sugimura K. J Magn Reson Imaging; 2007 Oct 01; 26(4):1071-80. PubMed ID: 17896365 [Abstract] [Full Text] [Related]
16. [Lung cancer detected by fluorodeoxyglucose-positron emission tomography/computed tomography in the course of Mycobacterium avium infection; report of a case]. Adachi K, Kaneda M, Sakai T, Fujimoto H, Ibata H, Omoto Y, Watanabe F. Kyobu Geka; 2009 Oct 01; 62(11):1019-21. PubMed ID: 19827559 [Abstract] [Full Text] [Related]
17. [Detection of unknown primary tumor in a patient with cerebellar metastasis using FDG PET-CT: case report]. Ishiguro T, Fu Y, Sadatou T, Shimokawa N, Shibamoto K. No Shinkei Geka; 2006 Oct 01; 34(10):1027-32. PubMed ID: 17052015 [Abstract] [Full Text] [Related]
18. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O. Otolaryngol Head Neck Surg; 2007 Jul 01; 137(1):130-7. PubMed ID: 17599580 [Abstract] [Full Text] [Related]
19. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F. Q J Nucl Med Mol Imaging; 2005 Sep 01; 49(3):259-66. PubMed ID: 16172572 [Abstract] [Full Text] [Related]
20. [Positron emission tomography (PET)-computed tomography (CT) suggesting small intestinal metastasis from lung cancer; report of a case]. Shiono S, Masaoka T, Sato T, Yanagawa N. Kyobu Geka; 2006 May 01; 59(5):426-9. PubMed ID: 16715897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]